ABSTRACT
defect in metal metabolism demonstrated in human fibroblasts, that should prove valuable in both the diagnosis of Menkes disease and in the study of the fundamental defect of this genetic disorder.
Menkes kinky-hair disease is an X-linked, recessively inherited disorder characterized by severe mental retardation, abnormalities in hair structure, bone and connective tissue degeneration, hypothermia, and low serum copper ceruloplasmin concentrations. These symptoms have been attributed to copper deficiency (1) , since copper is known to have a role in the formation of myelin, keratin, melanin, elastin, collagen, and ascorbic acid metabolism as well as in electron transport (2) . We culture solutions was monitored, and while some variations were observed for these solutions, no effect upon copper concentration of the fibroblasts was detected. The average copper concentration for the media was 54.1 ng of copper per ml. The copper concentration of the media was varied from 38 to 85 ng of copper per ml by the addition of copper sulfate. Subcultures from a single Menkes and a single control line were incubated in this medium for 4 days before copper analyses. Despite 
We also examined whether a difference in culture confluency existed between Menkes and control cultures and whether the copper content was influenced by variation in culture density. Harvesting of the cultures occurred when cell growth across the bottom surface of the containers was confluent. Both Menkes and control cultures required 8-10 days to obtain confluency. This implied not only similar growth rates, but also similar culture size at the time of analyses. Furthermore, investigations utilizing total protein con- It appears that control cultures cannot be differentiated from heterozygote cultures by copper content. Cultures from two presumed-heterozygote mothers of Menkes patients were grown and analyzed by the same procedures. The copper concentrations of these cultures fell within the statistically defined range for control values. This observation does not preclude the presence of cells expressing the abnormality, as would be predicted from the Lyon hypothesis. We would assume that when we examine cloned cells from known heterozygotes they will demonstrate both a normal and a mutant population.
We have also measured the copper content of two cultures from individuals with Wilson's disease, another genetic disorder involving copper metabolism. While the copper concentrations of these cultures were found to exceed those of controls (mean = 105.3 ng of copper per mg of protein), the Wilson cultures' copper content was distinct and much lower than the values observed for Menkes. Our experience with the cultures from patients with Wilson's disease is too limited to discuss fully any possible significance of the slightly elevated copper content, although it may be related to the abnormal protein reported by Evans et al. (5) . DISCUSSION The genetic marker for Menkes disease, consistently expressed as elevated intracellular copper concentration, provides a much more specific method for the diagnosis of this genetic disorder than those previously suggested (6, 7). Since it is logical that fetal cell cultures of individuals with Menkes disease would express the genetic anomaly as increased copper concentration, prenatal diagnosis may be possible. While this hypothesis remains to be tested, data indicate that fibroblasts cultured from normal amniotic fluid consistently exhibit copper concentration values similar to, but slightly less than, those of control cultures of skin fibroblasts (Table 1) (46, XY) , the presence of widespread abnormalities such as gaps, breaks, and rearrangements was noted. Although mycoplasma screening was negative these chromosomal anomalies suggest infection, which might affect copper concentrations. We have not included data from GM 245 in this report. We were fortunate to obtain a fresh biopsy of the same individual who was the source of the subculture GM 245. Subsequent analyses of the resulting fibroblast culture reveal a mean of 314.4 ng of copper per mg of protein. Thus far, no variation in either the copper content or growth behavior, as was observed in GM 245, has been detected.
In summary, the consistently elevated intracellular concentrations of copper in skin fibroblasts cultured from patients with Menkes disease set them apart from fibroblasts cultured from control subjects, presumed heterozygotes, and patients with Wilson's disease, and provide an in vitro marker for this disorder. This genetic marker should prove valuable in the diagnosis and perhaps antenatal detection of Menkes disease. The Menkes culture with this marker provides a unique tool for the further elucidation of the fundamental defect in Menkes disease as well as for investigating aspects of normal copper metabolism. Preliminary uptake studies with64Cu demonstrated very striking differences between Menkes and control cultures.
